About Us

Our Mission

The PCCTC’s distinguished investigators work together on a single mission: to design, implement and complete hypothesis-driven trials in prostate cancer, translating scientific discoveries to improved standards of care. We offer services to carry out this mission ensuring efficient trial selection, reporting, site management, clinical operations and data analyses.

Our History

The Prostate Cancer Clinical Trials Consortium (PCCTC) was initiated in 2005 by the Prostate Cancer Foundation (PCF) and the U.S. Department of Defense (DOD) Prostate Cancer Research Program (PCRP) in response to critically unmet needs in prostate cancer clinical research identified by physician investigators and patient advocates. To fulfill our mission, we developed a unique infrastructure which has fostered a culture of transparent project co-development between investigators, research sites and industry partners. Established as an independent entity in 2014, the PCCTC, LLC is now the nation’s premier multicenter clinical research organization specializing in cutting-edge prostate cancer research. Through the collaborative nature and intellectual synergy of our leadership, the PCCTC remains poised to make a significant impact on the lives of patients by keeping the pipeline primed with the most promising novel agents and validated biomarkers.

Our Leadership

Management Team

Jake Vinson

CEO

Howard I. Scher, MD

Chairman, Scientific
Oversight Committee

Michael J. Morris, MD

Medical Director

Sarah Wise

Director, Research Operations

Julie Filipenko

Director, Clinical Data
Management and Informatics

Board of Managers

Peter T. Scardino, MD, Chairman

Paul Sabbatini, MD, MSKCC Designated Officer

Mark Svenningson, Treasurer

Howard I. Scher, MD, Scientific Oversight Committee Chairman

Charles L. Sawyers, MD, Member

Leo F. Mullin, Member

Scientific Oversight Committee

Howard I. Scher, MD (Chairman), Memorial Sloan Kettering Cancer Center

Mary-Ellen Taplin, MD, Dana-Farber / Harvard Cancer Center

Daniel George, MD, Duke Comprehensive Cancer Center

Michael Carducci, MD, Johns Hopkins Sidney Kimmel
Comprehensive Cancer Center

Maha Hussain, MD, Northwestern University

Tomasz M. Beer, MD, Oregon Health and Science University
Knight Cancer Institute

Celestia Higano, MD, University of Washington Fred Hutchinson
Cancer Research Center

Charles Ryan, MD, University of Minnesota

Glenn Liu, MD, University of Wisconsin Carbone Cancer Center

Walter Stadler, MD, The University of Chicago Comprehensive Cancer Center

Mark N. Stein, MD, Rutgers Cancer Institute of New Jersey

Elisabeth Heath, MD, Barbara Ann Karmanos Cancer Institute

Matthew Rettig, MD, UCLA Jonsson Comprehensive Cancer Center

David M. Nanus, MD, Weill Cornell Medical College

W. Kevin Kelly, DO, The Sidney Kimmel Cancer Center at
Thomas Jefferson University

Our Participants

Participating Clinical Research Sites

Australian Urology Associates

Baylor College of Medicine

BC Cancer Agency (Canada)

Beth Israel Deaconess Medical Center

Carolina Urologic Research Center

Centro de Pesquisa em Oncologia (Brazil)

Chesapeake Urology Associates

Christiana Care Health Services

CHU de Montreal (Canada)

CHU de Québec Université Laval (Canada)

City of Hope National Medical Center

Columbia University

Comprehensive Cancer Center Nevada - US Oncology

Dana-Farber / Harvard Cancer Center

Duke Comprehensive Cancer Center

Durham VA Medical Center

Decatur Memorial Hospital

Eastern Health (Australia)

Emory University

Epworth Healthcare (Australia)

Erasmus Medical Center (Netherlands)

GU Research Network

Guys and St. Thomas NHS Foundation Trust (United Kingdom)

H. Lee Moffitt Cancer Center & Research Institute

Indiana University

James J. Peters VA Medical Center

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

Juravinski Cancer Centre (Canada)

Kantonsspital Graubünden (Chur) (Switzerland)

Kantonsspital St. Gallen (Switzerland)

Macquarie University (Australia)

Mayo Clinic (Scottsdale & Jacksonville)

Memorial Sloan Kettering Cancer Center

Midlantic Urology

Millennium Physicians Association

New Mexico Cancer Care Alliance

New York University

Northshore Kellogg Cancer Center

Northwestern University

Örebro University Hospital (Sweden)

Oregon Health and Science University Knight Cancer Institute

Ottawa Hospital Cancer Centre (Canada)

Queensland University of Technology (Australia)

Rhode Island Hospital

Roswell Park Cancer Institute

Rush University Medical Center

Skåne University Hospital (Sweden)

Ter Gooi Ziekenhuis (Netherlands)

The Christie NHS Foundation Trust (United Kingdom)

Tulane University

UCLA Jonsson Comprehensive Cancer Center

University of Alabama

University of California San Diego

University of California San Francisco Helen Diller Family Cancer Center

University of Chicago

University of Minnesota

University of North Carolina

University of Utah

University of Virginia

University of Washington Fred Hutchinson Cancer Research Center

University of Wisconsin Carbone Cancer Center

Virginia Oncology Associates

Washington University St. Louis

Wayne State University / Karmanos Cancer Institute

Weill Cornell Medical College

Westmead Hospital (Australia)

Yale Cancer Center

Committed to world-class science!

Our services translate scientific discoveries into improved standards of care, ensuring efficient trial selection, reporting, site management, clinical operations and data analyses.